Literature DB >> 9007492

Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants.

G Dimitriou1, A Greenough, F J Giffin, V Kavadia.   

Abstract

UNLABELLED: The speed of action and side-effects of systemic verus inhaled steroids was compared in infants with mild-moderate oxygen dependency. Forty infants (median gestational age 27 weeks) were randomized to receive either 10 days of dexamethasone (systemic group) or budesonide (100 micrograms qds) (inhaled group). At randomization, there was no significant difference in the gestational or postnatal age, inspired oxygen requirements or compliance of the respiratory system of the two groups. After 36 h of treatment, there were significant changes (P < 0.01) in both the inspired oxygen concentration and compliance of the respiratory system in the systemic but not the inhaled group. Only after 1 week of inhaled therapy were improvements in respiratory status noted but, even at that time, the inspired oxygen requirement was significantly lower in the systemic versus the inhaled group. In the systemic group only, however, were there significant increases in blood pressure.
CONCLUSION: Systemically administered rather than inhaled steroids appear to have a faster onset of action.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9007492     DOI: 10.1007/s004310050552

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Growth effects of systemic versus inhaled steroids in chronic lung disease.

Authors:  R M Nicholl; A Greenough; M King; P Cheeseman; H R Gamsu
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

3.  Post-natal corticosteroid use.

Authors:  Olivia Williams; Anne Greenough
Journal:  Eur J Pediatr       Date:  2003-07-16       Impact factor: 3.183

Review 4.  Review of the antenatal and postnatal use of steroids.

Authors:  Julie Bartholomew; Lajos Kovacs; Apostolos Papageorgiou
Journal:  Indian J Pediatr       Date:  2014-03-30       Impact factor: 1.967

Review 5.  Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

Authors:  Wes Onland; Martin Offringa; Anton van Kaam
Journal:  Cochrane Database Syst Rev       Date:  2017-08-24

Review 6.  Updates on Functional Characterization of Bronchopulmonary Dysplasia - The Contribution of Lung Function Testing.

Authors:  Anne Greenough; Anoop Pahuja
Journal:  Front Med (Lausanne)       Date:  2015-05-29

7.  Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.

Authors:  Viraraghavan Vadakkencherry Ramaswamy; Tapas Bandyopadhyay; Debasish Nanda; Prathik Bandiya; Javed Ahmed; Anip Garg; Charles C Roehr; Sushma Nangia
Journal:  JAMA Pediatr       Date:  2021-06-07       Impact factor: 16.193

Review 8.  Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.

Authors:  Brian J Clouse; Sudarshan R Jadcherla; Jonathan L Slaughter
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

Review 9.  Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.

Authors:  Zhi-Qun Zhang; Ying Zhong; Xian-Mei Huang; Li-Zhong Du
Journal:  BMC Pulm Med       Date:  2017-12-15       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.